Is the recurrence rate of lung cancer high?

The recurrence and mortality rates of patients with advanced lung cancer are very high. The determination and selection of treatment plans for advanced lung cancer are the key to the survival of lung cancer patients. Only effective treatment plans can improve the survival time of patients. So is the recurrence rate of lung cancer high?

After a long process of diagnosis and treatment, many lung cancer patients finally come to an end. At this time, they must not take it lightly and make preparations to prevent recurrence. To overcome the recurrence of lung cancer, it is necessary to do a good job of postoperative care for lung cancer. Some people do not understand this. They also take care of the patients after surgery and are discharged from the hospital only if there is no abnormality. So, why does lung cancer recur after surgery?

Chemotherapy is one of the systemic treatments for advanced lung cancer. It has a relatively direct inhibitory effect on cancer, but it has the shortcoming of "not distinguishing between friend and foe."

According to experts, DC-CIK biological immunotherapy for lung cancer can systematically kill tumor cells and effectively solve the problem of metastasis and spread, overcoming the shortcomings of the three traditional treatment methods of surgery, radiotherapy and chemotherapy, such as "incomplete, easy to metastasize, and large side effects". If DC-CIK biological immunotherapy is used during and after chemotherapy, it can better alleviate the chemotherapy reaction and help the chemotherapy proceed smoothly. Choosing a good treatment plan is critical for the treatment of advanced lung cancer. Patients can improve their own immune "self-healing power", reduce pain, and strengthen the prevention and treatment of lung cancer recurrence and metastasis through combined DC-CIK biological immunotherapy, thereby effectively curbing the brain metastasis of lung cancer.

Somatic cell technology breaks through the three bottlenecks of traditional tumor treatment: "incomplete", "easy to relapse", and "significant side effects". It fully combines cytology and immunology, using the patient's own cells to treat his own disease. The effect is ideal and rapid, and there are no toxic side effects. It is worth noting that these immune cells injected back into the human body can survive for a long time, continue to eliminate viruses, and are not prone to relapse.